Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Teva
Accenture
Citi
Cantor Fitzgerald
Daiichi Sankyo
Federal Trade Commission
Deloitte
Johnson and Johnson

Generated: April 25, 2018

DrugPatentWatch Database Preview

ZONALON Drug Profile

« Back to Dashboard

When do Zonalon patents expire, and when can generic versions of Zonalon launch?

Zonalon is a drug marketed by Mylan Pharms Inc and is included in one NDA.

The generic ingredient in ZONALON is doxepin hydrochloride. There are seven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.
Drug patent expirations by year for ZONALON
Pharmacology for ZONALON
Medical Subject Heading (MeSH) Categories for ZONALON
Synonyms for ZONALON
(3-(6H-dibenzo[c,f]oxepin-11-ylidene)propyl)dimethylamine, chloride
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-1-propanamine hydrochloride
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine hydrochloride
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine hydrochloride
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride
(3e)-3-(Dibenzo[b,E]oxepin-11(6h)-Ylidene)-N,N-Dimethylpropan-1-Amine
(3E)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine
(3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-di(methyl)propan-1-amine
(3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine
(E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine
(e)-doxepin
(e)-doxepin hydrochloride
[11C]-doxepin
[11C]doxepin
1-Propanamine, 3-dibenz(b,e)oxepin-11-(6H)-ylidene-N,N-dimethyl-dimethyl-, hydrochloride, (E)-
1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl-
1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)ylidene-N,N-dimethyl-, hydrochloride
11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin hydrochloride
11-(3-(Dimethylamino)propylidene)-6H-dibenz(b,e)oxepine
11-(3-Dimethylamino-propyliden)-6,11-dihydro-dibenz(b,e)oxipin
11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz(b,e)oxipin
11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepine hydrochloride
1229-29-4
1668-19-5
20917-44-6
229D294
25197-84-6
3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine
3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine
3607-34-9
4698-39-9
5EH
851NLB57HQ
A804993
AB0109368
AC1LDI63
AC1O4WGB
Adapin
Adapine (TN)
AJ-08007
AK-60057
AK-70938
AKOS015895087
AKOS016014904
Aponal
Aponal (TN)
AX8126881
BC225584
BDBM112780
BG0175
BPBio1_000118
BRD-K36616567-003-01-5
BRD-K54462405-003-03-3
BSPBio_000106
C06971
C19H21NO
C19H21NO.HCl
CAS-1229-29-4
CCG-204434
CCG-220263
CCG-221643
CCRIS 9176
CHEBI:4711
CHEMBL1200462
CHEMBL860
Cidoxepin [INN]
Cidoxepina
Cidoxepinum
cis-N-(3-(6H-Dibenz(b,e)oxepin-11-yliden)propyl)-N,N-dimethylamin
CPD000058230
CS-2972
CU61C5RH24
Curatin
D 4526
D00814
D06EUH
D06FES
D07875
Deptran
Deptran (TN)
Dibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine, N,N-dimethyl-, hydrochloride
Dibenz(b,e)oxepin-delta(sup 11(6H)),gamma-propylamine, N,N-dimethyl-
Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N,N-dimethyl-, hydrochloride
Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N,N-dimethyl-, hydrochloride (8CI)
dimethyl({3-[(2E)-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine
DIMETHYL({3-[(2E)-9-OXATRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-2-YLIDENE]PROPYL})AMINE
dimethyl(3-{9-oxatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}propyl)amine
doxepin
Doxepin (Hydrochloride)
Doxepin (INN)
Doxepin (Z)-isomer
Doxepin [INN:BAN]
Doxepin [USAN]
Doxepin for system suitability, European Pharmacopoeia (EP) Reference Standard
Doxepin HCl
Doxepin hydrochlorid
Doxepin Hydrochloride
Doxepin hydrochloride (E)-isomer
Doxepin hydrochloride (USP)
Doxepin hydrochloride [USAN:USP]
Doxepin Hydrochloride [USAN]
Doxepin Hydrochloride 1.0 mg/ml in Methanol (as free base)
Doxepin Hydrochloride,
Doxepin hydrochloride, ~85% E-isomer basis, >=98% (GC), 15% Z-isomer basis, powder
Doxepin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Doxepin hydrochloride, United States Pharmacopeia (USP) Reference Standard
Doxepin, (E)-
Doxepin, Hydrochloride
Doxepina
Doxepina [INN-Spanish]
Doxepine
Doxepine hydrochloride
Doxepinum
Doxepinum [INN-Latin]
DR000955
DSSTox_CID_25145
DSSTox_GSID_45145
DSSTox_RID_80701
DTXSID7022966
DTXSID8045145
E-DOXEPIN
EINECS 214-966-8
EU-0100339
GTPL1225
GTPL3958
HMS1568F08
HSDB 3069
HY-B0725
I06-0502
J10288
Jsp001539
KB-233534
KS-5094
L000699
Lopac-D-4526
Lopac0_000339
LP00339
LS-174582
LS-61638
LS-61639
MF 10
MF 10 HCl
MFCD00079135
MLS000069794
MLS001148235
MLS002207250
MLS002222181
MLS002548858
MOLI001594
MolPort-003-872-120
N,N-Dimethyldibenz(b,e)oxepin-delta(11(6H),gamma)-propylamine
N,N-Dimethyldibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine hydrochloride
NC00447
NCGC00015344-01
NCGC00015344-02
NCGC00015344-03
NCGC00015344-04
NCGC00024623-01
NCGC00024623-04
NCGC00093778-01
NCGC00093778-02
NCGC00162127-01
NCGC00261024-01
Novoxapin
Novoxapin hydrochloride
NSC-108160
Opera_ID_675
P-3693A
PL047943
Prestwick_187
Prestwick2_000263
Prestwick3_000263
Q-201044
Quitaxon
SAM002264608
SBB005916
SCHEMBL116895
SCHEMBL60287
Silenor
Sinequan
Sinequan (TN)
Sinequan, Zonalon
Sinequin
Sinquan (TN)
SMR000058230
SR-01000075551
SR-01000075551-1
ST025239
Tocris-0508
Toruan
Tox21_110130
Tox21_110130_1
Tox21_500339
trans-doxepin
trans-Doxepin hydrochloride
Triadapin
UNII-3U9A0FE9N5 component MHNSPTUQQIYJOT-SJDTYFKWSA-N
UNII-5ASJ6HUZ7D component ODQWQRRAPPTVAG-GZTJUZNOSA-N
UNII-851NLB57HQ
UNII-CU61C5RH24
US8629135, SW-07
Xepin (TN)
ZINC1331
Zonalon (TN)

US Patents and Regulatory Information for ZONALON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc ZONALON doxepin hydrochloride CREAM;TOPICAL 020126-001 Apr 1, 1994 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Express Scripts
Merck
Accenture
Argus Health
US Army
Medtronic
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.